DRUG · Mapped RxNorm record
Aflibercept Injection [Eylea]
Normalized identity: aflibercept Injection [Eylea]View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection
NCT03453281
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedEarly Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Aflibercept Injection [Eylea]DRUG · verified · RxNorm: aflibercept Injection [Eylea]
Sponsors & collaborators
Universitas Indonesialead sponsor
Bayercollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03453281 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.